Molecure S.A.

zł 5.56As of Sun 8 Nov 2026, 12:00 UTC
WSE:MOCHealthcare
Country Poland
PE (Fwd) •••
TSR 9Y CAGR (16.17%)
Div yield —
ROE (16.27%)
Biotechnology
Beta (5Y) 1.02
PE TTM —
TSR TTM (14.46%)
Mkt cap zł 114.6M
ROIC (22.82%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
zł 6.17
10.92%
(87.04%)
Hold 8|9|4|4|7
4Q25
1Q26
2Q26
3Q26
Earnings per sharezł
0.10
0.10
0.09
0.10
10.26%
(1.72%)
(12.84%)
(0.36%)
Revenuezł M
5.605
5.556
5.411
5.264
16.39%
12.68%
3.72%
(4.21%)
Peers (US$28.93M)
Cap (US$)
PE
31.51M
—
28.69M
—
24.17M
—
Capital
TTM
5Y
10Y
Leveragex
1.391
(0.205)
(0.228)
EBIT/Intx
1.968
0.210
0.210
Own earn%
576.11
(52.30)
(47.91)
Sh yield%
46.17
39.68
42.09
Owners
Insiders/Inst%
2.28
41.09
Short interest%
4.39
SBC / revenue%
2.23
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
24
Op margin range%
13–18
$1 testx
0.1
Incr. ROIC%
16